EMA
approval
· 2026-06-12
EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited
Summary
Amlodipine besilate/valsartan combination (Amlodipine besilate; valsartan) by Mylan Pharmaceuticals Limited has been authorised for hypertension in the EU.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Hypertension. MAH: Mylan Pharmaceuticals Limited. Decision date: 08/06/2026